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Abstract: The effect of IFNα-2b on the migration, proliferation, and expression of epithelial and mesenchymal markers of MCF-7 tumor
adenocarcinoma cells in 2D and 3D cell cultures was examined. A significant cytostatic effect of IFNα-2b on the tumor population
was detected. It was found that changes in the expression of epithelial (CKs and EpCAM) and mesenchymal markers were caused by
changing the growth type of the tumor population. IFNα-2b inhibited migration of tumor cells to the suspension fraction and promoted
an increase in expression of CK and EpCAM in 2D and 3D cell cultures, but only in the 3D culture was expression of vimentin increased.
IFNα-2b caused an increase in CK and EpCAM expression by 50.5% and 47.8%, respectively, compared with the control in the 2D
cell culture. In the 3D cell culture this increase was 33% and 34%, respectively, compared with the control. IFNα-2b stimulated the
differentiation and inhibited the migrational ability of tumor cells in the early stages of breast cancer development.
Key words: Breast cancer, MCF-7, 2D cell culture, multicellular tumor spheroids, interferon alfa

1. Introduction
It is generally accepted that cancer cells arise from healthy
cells that have undergone genetic or epigenetic changes
(Erenler and Geçkil, 2014). During tumor development,
the tumor microenvironment, which contains stromal and
immune cells as well as cytokines produced by these cells,
plays a determining role (Hanahan and Coussens, 2012).
Previous studies have shown that different populations
of immune cells and the molecules they produce are
important in the progression of tumors (Zarour, 2016).
It is also well known that the growth of most malignant
neoplasms is accompanied by certain impairment of the
immune response (Kadegidze et al., 2013). Inflammatory
reactions play an important role in all stages of the
development of the tumor, such as the formation of
micrometastases, the acquisition of malignant phenotypes,
and intravascular spread. These data served as the basis for
the widespread use of oncology therapeutic agents that can
restore the functions of the immune system. Interferons
(IFNs) are one of the most important regulators of the
human immune system. They are a group of cytokines
that are able to exert direct and indirect effects on tumor
cells. Thus, interferons have antiproliferative, antiviral,
and immunomodulating properties (Hsu et al., 2016).
Due to this, IFNα-2b is used as an antiproliferative agent

during monotherapy or combination therapy with other
antitumor drugs (Ningrum, 2014). IFNα-2b is of obvious
importance in anticancer therapy because it affects all
aspects of cellular and humoral immunity, regulation of
hematopoiesis, and synthesis and production of various
cytokines, causing an inhibitory effect on malignant cells.
Shift to the mesenchymal phenotype causes an increase
in the migratory capacity of tumor cells (Lamouillle et
al., 2014). Epithelial–mesenchymal transition (EMT)
can also be caused by local inflammation. During this
process, tumor cells partially or completely lose their
epithelial characteristics (EpCAM and CK) and acquire
mesenchymal phenotypes (vimentin), which increase
tumor cell plasticity, so as to easily escape from the primary
tumor into blood (Kim et al., 2014). Few researchers
have addressed the question of searching for factors that
can inhibit the transition of the cell population from
the epithelial to the mesenchymal phenotype (SuarezCarmona et al., 2017). The past decade has seen renewed
importance placed on interferon alfa (IFNα-2b) as a factor
capable of modifying EMT of the tumor population during
the development of the tumor process. Several authors
have shown that long-term therapy of human cancer
cells using this cytokine leads to changes in epithelial and
mesenchymal markers indicating suppression of the EMT
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program (Semesiuk et al., 2011). Since EMT is associated
with processes for the migration of tumor cells and the
formation of micrometastases, it is extremely important to
study the effect of IFNα-2b on this process.
Cancer cell lines are widely used as models for
studying the mechanisms of cancer development and
the study of the effectiveness of antitumor agents. The
environment conditions in monolayer culture (2D) in
vitro differ significantly from in vivo conditions, since the
tumor population is fairly heterogeneous and consists of
cells at different stages of development and differentiation.
In addition, in natural conditions, cells in the tumor
interact with adjacent cells and the extracellular matrix,
and also have different access to nutrients and oxygen
(Vidyasekar et al., 2016). Often these differences are the
cause of the ineffectiveness of antitumor therapy, which
showed promising results in preclinical studies in 2D cell
growth conditions in vitro. An alternative model for the
study of tumor cell susceptibility to antitumor agents is
multilayered spherical 3D cultures or multicellular tumor
spheroids (MCTSs) (Friedrich, 2007).
Cells in 3D culture actively interact with each other,
the extracellular matrix, and the microenvironment.
Such interactions affect cell proliferation, differentiation,
and morphology; gene expression; and protein synthesis.
The structure of 3D tumor aggregates is similar to that of
a tumor at an early avascular stage of development or to
micrometastases. In addition, MCTSs consist of cells that
are at different stages of their development and under
different influences (proliferative, restless, apoptotic,
hypoxic, and necrotic cells) (Kim, 2005). Due to their
structure, MCTSs are important for testing the therapeutic
effect of antitumor drugs, as well as for assessing the
invasive capacity of transformed cells. The aim of the
present study was to evaluate the effect of IFNα-2b on the
migration, proliferation, and expression of epithelial and
mesenchymal markers of MCF-7 tumor adenocarcinoma
cells in 2D and 3D cell cultures.
2. Materials and methods
2.1. Cultivation of the monolayer culture
MCF-7 cells were obtained from the Cell Line Bank of the
Kavetskii Institute of Experimental Pathology, Oncology,
and Radiobiology, National Academy of Sciences of
Ukraine, and maintained in DMEM (Sigma, St. Louis, MO,
USA) with 40 mg/mL gentamicin (Biopharma, Ukraine),
2 mM L-glutamine (Sigma), and 10% fetal bovine serum
(FBS) (Sigma) in a 5% CO2 incubator that was maintained
at 37 °C. Initial cell density was 2 × 104 cells/cm2. The cells
were used in the experiments after 2 days of incubation.
2.2. Cultivation of the spheroid culture
MCTS generation started with cell removal from the
substrate using 0.25% trypsin-EDTA (Sigma) and
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transfer to DMEM with 2% carboxymethyl cellulose (BioRad, Hercules, CA, USA) to the final concentration of 5 ×
105 cells/mL. The cells were subsequently incubated in an
orbital shaker (PSU-10i, Biosan, Riga, Latvia) at 80 rpm
for 3–5 h. Half of the culture medium was changed every
3 days. The spheroid cultures were maintained for 7 days
under these conditions.
2.3. Cell proliferation and viability
The effect of IFNα-2b on the proliferative activity and
adhesion properties of the tumor population was analyzed
in MCF-7 cells incubated with IFNα-2b (Laferobion,
Biopharma, Kyiv, Ukraine) at concentrations of 103,
104, and 105 U/mL. The dye exclusion test was used to
determine the number of viable cells present in a cell
suspension and adhesion after 24 h. It is based on the
principle that live cells possess intact cell membranes that
exclude certain dyes, whereas dead cells do not. We mixed
20 μL of 0.4% Trypan blue solution with 20 μL of the cell
suspension and counted the number of living cells using
a hemocytometer. Cells incubated in standard DMEM
under standard conditions were used as controls. Cell
viability was evaluated by MTT assay (Mossman, 1983).
MCF-7 cells were incubated at 1 × 104 cells/well in a 96well plate and grown overnight. The cells were treated
with various concentration of IFNα-2b, as indicated, for
24 h and 48 h. At the end of these periods, 100 μL of MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) at a dose of 5 mg/mL (Sigma) was added to
each well, followed by further incubation for 4 h at 37 °C.
The supernatant was removed and then 400 μL of 0.1%
dimethyl sulfoxide was added to all wells to dissolve the
purple formazan crystals. The dissolved crystals were
transferred to a 96-well plate for reading and measured with
a microplate spectrophotometer (Thermo/LabSystems 352
Multiskan MS Microplate Reader) at a wavelength of 540
nm.
2.4. Morphometric assay of MCTSs
The cell aggregates were photographed after 7 days of
cultivation and their sizes were measured in order to
characterize the parameters of MCTSs in the 3D culture.
Stemi 2000 software (Zeiss, Germany) was used for image
processing, and the Bjerkvig formula (V = 0.4 × a × b2, a –
largest size of spheroid, b – smallest size of spheroid) was
used to calculate aggregate volume (Bjerkvig, 1991).
2.5. Immunohistochemistry
The expression of markers under the influence of IFNα2b was assessed in 2D cultures maintained on glass
coverslips in 6-well plates at a density of 2 × 104 cells/
cm2. Receptor expression was analyzed after 2 days of
incubation. The MCTSs were embedded in paraffin blocks.
The markers were visualized immunohistochemically
with the following monoclonal primary antibodies:

HERHELIUK et al. / Turk J Biol
CK (clone AE1/AE3, IS053, Dako, Carpinteria, CA,
USA), vim (Clone V9, IS630, Dako), and EpCAM
(HPA026761, Sigma, Stockholm, Sweden). Histological
samples of the cells were photographed for comparing
the morphological characteristics and expression of
the receptors in both monolayer and spheroidal cell
cultures. In the cell cultures under study, the number of
immunopositive/immunonegative cells was determined.
The number of immunopositive cells was counted in 10
randomly selected microscope fields for each sample using
a standard measuring scale (object - micrometer) at the
same magnitude and calculated as a percentage of the total
number of cells taken at 100%. At least 1000 cells were
counted.
2.6. Cell cycle analysis
Cell cycle analysis was performed using propidium iodide
staining, as described previously (Zhao et al., 2015).
Distribution of the MCF-7 cell population by cell cycle was
determined by flow cytometry (Becton Dickinson) at λir =
488 nm and λem = 585/40 nm.
2.7. Statistical analysis
One-way analysis of variance and Student’s t-test used for
statistical processing of the data were implemented in the
software package Statistica 8. The significance threshold
was set at P ≤ 0.05. The results are presented as mean
values and standard error values (M ± SE).
3. Results
In the first stage of tumor formation, we evaluated the
survival and proliferative activity of tumor cells when they
were incubated with IFNα-2b by MTT analysis in a cell
monolayer culture at different concentrations of IFNα-2b
after 24 and 48 h of cultivation. Survival of tumor cells
in control specimens under standard culture conditions
was taken as 100% (Figure 1). Figure 1 shows the
cytotoxic effect of IFNα-2b on the first and second days of
cultivation. Thus, the reduction in survival of tumor cells
was maximal at the IFNα-2b concentration of 104 U/mL
on the second day of cultivation. It was also found that
survival of tumor cells incubated in the presence of IFNα2b was lower by 47% compared with control samples. It is
interesting that cell viability increases in a concentration
of 105 U/mL and the numbers of living cells are more than
103 and 104 U/mL after 24 h of incubation. IFN-α has a
pleiotropic effect, because it stimulates antitumor immune
response and also directly affects the proliferation and
survival of tumor cells. However, as it turned out, these
are not all the positive effects of this cytokine. Ma et al.
(2017) demonstrated that IFNα can upregulate cancer
stem cell (CSC) markers and can activate dormant CSCs.
They found that IFN-α can enrich tumors by CSCs while
at the same time killing the bulk of tumor cells. That is why
we think that in the present time of cultivation IFNα-2b at

Figure 1. Survival of MCF-7 cells in the monolayer culture with
various concentrations of IFNα-2b (102, 103, 104, 105 U/mL). Cell
viability (%) was determined by the MTT assay on the first and
second days of cultivation, *, # - P ≤ 0.05.

concentration 105 U/mL enhanced the number of living
cells, because the population of CSCs was differentiated
into tumor cells. However, after 24 h (48 h of cultivation)
IFNα-2b inhibited the proliferation of tumor cells because
of its cytotoxicity effect.
The ability of tumor cells for substrate-independent
growth underlies the processes of migration and metastasis.
The data obtained in the first stage give an understanding
of the general survival of the cell population of a monolayer
culture. However, an indicator of the migration activity of
tumor cells is the change in adhesion ability. In order to
evaluate the adhesion potential of tumor cells, we analyzed
how the composition of the adhesion and suspension
fraction of monolayer culture changes over 4 days of
cultivation. MCF-7 cells were incubated with IFNα-2b at
a concentration of 2 × 104 U/mL. Every 24 h living cells
were counted in the suspension and adhesive fractions
(Figures 2A and 2B). The present study showed that IFNα2b had a cytostatic effect on the tumor population, keeping
the number of living cells in both the suspension and the
adhesion fraction at a level lower than the control. It was
demonstrated that the number of living cells cultured with
IFNα-2b in the adhesion fraction showed a cytotoxic effect
of cytokine on days 3–4 of cultivation (Figure 2A), since
during this period there was a decrease in the number
of cells by 29% and 59%, respectively, in comparison
with the control. In the suspension fraction, on day 4 of
cultivation (Figure 2B), the number of cells was less than
40% compared to the control. At about 72 h, the number
of living cells decreases in both the control and IFNα-2b
groups in the adhesion fraction with the same slope, at
almost the same time. However, in Figure 2A the number
of living cells in the suspension fraction increases after 72
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Figure 2. Survival of MCF-7 cells in the presence of IFNα-2b, suspension (A), and adhesive (B) fraction, * - P ≤ 0.05. Alive cells in the
suspension and adhesion fractions were counted after 24 h according to a conventional procedure that involved Trypan blue staining.

h of cultivation. The fact is that part of the adherent cells
go into suspension. At the same time, IFNα-2b inhibits the
transition from the adhesion to the suspension fraction,
compared with the control. We suppose that the migration
capacity of tumor cells is lower under the influence of
IFNα-2b.
MCTS is a model for the primary stage of development
of breast cancer, and so it is very important to evaluate
the effect of IFNα-2b precisely at this stage of disease
development. It is known that MCTSs in vitro are formed
as a result of migration and aggregation of cells (Vinci et
al., 2013). The analysis of the formation of MCTSs, based
on the average size of aggregates in culture, indicates a
decrease in the size of tumor spheroids that have been
incubated with IFNα-2b. The dose-dependent decrease in
spheroids was greater when IFNα-2b was added: 3.67 (102
U/mL) and 1.68 times (104 U/mL), respectively (Table 1).
Since interferons can act as cell cycle regulators, we
analyzed induction of apoptosis or cell cycle stop under the
influence of IFNα-2b in MCF-7 cells at a concentration of
104 U/mL. Analysis by flow cytometry showed that IFNα2b causes cellular accumulation in the G0/G1 phase (Table
2), which may indicate induction of apoptosis and cell
cycle arrest by this cytokine. The decreasing cell number
in the synthetic phase of the cell cycle possibly caused
inhibition of MAP kinase activity, a key regulator of Cdk
at different stages of the cell cycle.
The next step in the study was to analyze the expression
of epithelial (CK and EpCAM) and mesenchymal (vim)
markers under the influence of IFNα-2b. Thus, in the
monolayer culture of tumor cells in the presence of
cytokine (104 U/mL), the expression of CK and EpCAM
increased by 50.5% and 47.8%, respectively, as compared
with the control, but expression of vimentin was not
observed in this culture (Table 3).
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Table 1. Volume of multicellular tumor spheroids of the MCF-7
cell line after incubation with IFNα-2b. *Values ± standard error
after 5 repetitions are given, Р ≤ 0.05.
Concentration of
IFNα-2b, U/mL

Volume, mm*10–3

0

0.99 ± 0.05
2

10

0.27 ± 0.01

103

0.65 ± 0.03

10

0.46 ± 0.02

4

Table 2. Spreading of MCF-7 cell population on phases of the
cell cycle in the 2D cell culture under the influence of IFNα-2b
(104 U/mL).
Phases of
cell cycle

Control of
MCF-7 cells

MCF-7 cells +
IFNα-2b

G0/G1

41%

53%

G2/M

24%

29%

S

35%

18%

Table 3. Expression of tumor markers in the presence of IFNα2b, Р ≤ 0.05.
CK, %

EpCAM, %

Vim, %

2D control

33.5 ± 1.7

25.2 ± 1.3

0

2D + IFNα-2b

84 ± 4.2

73 ± 3.7

0

3D control

45 ± 2.3

26 ± 1.3

5 ± 0.3

3D + IFNα-2b

87 ± 4.3

60 ± 3.0

7 ± 0.4
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In the spheroid culture of tumor cells, the expression
of CK and EpCAM in the presence of interferon alfa
increased by 33% and 34%, respectively, compared with
the control. However, the increase in the expression of
vimentin was slightly different from that of the control (by
2%). Thus, interferon alfa enhances the expression of the
epithelial markers EpCAM and cytokeratins both in the
monolayer (Figure 3A) and in the cells of MCF-7 spheroids
(Figure 3B). Since there was an increase in the expression
of epithelial markers and there was no increase in the
expression of vimentin, it can be assumed that interferon
alfa did not lead to the EMT phenomenon, since tumor
cells, in contrast, acquire distinct signs of differentiation.

4. Discussion
It was shown that IFNα-2b inhibited the proliferation and
migration ability of MCF-7 cells. IFNα-2b also enhanced
expression of epithelial markers by MCF-7 cells in 2D and
3D cell cultures. Type I interferons (IFNα, IFNβ, IFNω)
are involved in the processes of anticancer defense and cell
differentiation, as well as being capable of increasing the
sensitivity of tumor cells to chemotherapy and radiation
therapy (Morak et al., 2011). These substances act through
the formation of a receptor complex after binding to a
receptor, which consists of two subunits of IFNAR-1 and
IFNAR-2. The IFNAR-2 subunit is represented by a soluble
form and can act as a dominant negative regulator of free

Figure 3. Expression of tumor markers in 2D (A) and 3D (B) MCF-7 cell cultures by IFNα2b (104 U/mL), microphotography, hematoxylin/eosin, 400× magnification: a) CK expression,
MCF-7 control, b) Expression of CK, MCF-7 + IFNα-2b, c) EpCAM expression, MCF-7
control, d) EpCAM, MCF-7 + IFNα-2b expression, e) Vim expression, MCF-7 control, f) Vim
expression, MCF-7 + IFNα-2b.
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Figure 3. (Continued).

interferons; the IFNAR-1 subunit is a shorter form in which
there are no cytoplasmic domains. IFNAR-2 contains the
whole cytoplasmic domain and, together with IFNAR-1,
is a functional IFNR receptor that is able to bind IFN and
induce JAK-STAT signaling (Bekisz et al., 2004). As is
known from the literature, IFNα stimulates phagocytosis
of macrophages and neutral granulocytes, and activates
the production of reactive oxygen species in them,
thereby increasing the cytotoxicity of cells, increasing the
synthesis of interleukin 1 (IL-1) phagocytes and tumor
necrosis factor (TNF-α), causing expression on HLA Class
I membranes required for the recognition of target cells,
including tumorous, cytotoxic lymphocytes, and for the
functioning of T-suppressors (Lisyany et al., 2004).
We suggest that IFNα-2b inhibits proliferation of breast
cancer cells in the system of 2D and 3D cell growth. Such
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an antiproliferative effect can be achieved by stopping
a cell cycle, apoptosis, or differentiation. In the body, its
action may be mediated by the activation of immune cells
(T cells and natural killers), inhibition of vascularization
(angiogenesis), and induction of cytokines that control
various processes in the cell, such as proliferation,
differentiation, survival, and apoptosis (Bekisz et al.,
2010). Compared to monolayer culture, MCTS cells are
less susceptible to IFNα-2b, due to the heterogeneity of
cell populations in this model. MCTS outer layers consist
of actively proliferating cells and the core of the unit is
enriched with cells in rest or hypoxia, because they receive
less oxygen, growth factors, and nutrients. It is also known
that MCTSs contain about 1% of stem cell tumors capable
of resuming a tumor cell population. In addition, 2D
and 3D cultures of cancer cells differ in the level of gene
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expression, the intensity of proliferation, and the ability of
cells to migrate and metastasize (Gurski et al., 2010).
One of the stages of the study of tumor cell susceptibility
to IFNα-2b was the analysis of the cell division cycle,
since its violation leads to uncontrolled growth of the
tumor population. Normally, cells in an organism are in
one of three states: in a loop, in a resting state, with the
preservation of the ability to return to the cycle, and in
the stage of final differentiation, when the ability to divide
is lost. Of course, tumors can form only those cells that
can actively divide. The spread of tumor cells and the
growth of the tumor is a complex process that involves
many successive stages, in which positive and negative
regulators of the cell cycle are involved. One of the crucial
stages of the cell cycle in mammalian cells is the G1 phase,
during which the cell “decides” to stop or continue a new
cell division cycle. Cell cycle regulation and proliferation
may be carried out, primarily, by extracellular signals, in
particular cytokines (interleukins and interferons) (Grana
and Reddy, 1995). We have shown that IFNα-2b stops
the cell cycle of cancer cells in the G0/G1 phase, causing
apoptosis. There are studies that confirm this finding
(Ossina et al., 1997; Chawla-Sarkar et al., 2001; Thyrell
et al., 2002). A team of scientists has shown that IFNα
can stop the cell cycle in the G1 phase by activating JAKSTAT signaling, and also suppresses proliferation of tumor
cells. In other studies, the value of IFNα as a regulator of
expression of cyclin-dependent kinase inhibitors (Cdks)
is described; furthermore, p21 induction is a major event
in the regulation of the cellular cycle mediated by IFNα
(Szeps et al., 2003). When cells of epithelial origin, in this
case tumor cells of the mammary gland, become signs of
the mesenchymal phenotype, they acquire the ability to
suppress the antitumor protective forces of the organism,
migrate to the body, become incapable of apoptosis and
insensitive to the action of antitumor drugs, and act as
a reservoir that replenishes and expands a population
of tumor cells (Marcucci et al., 2016). Tumor cells that
undergo EMT are actively proliferating and self-renewed,
resulting in an increase in the number of heterogeneous

populations. As a result, the pool of migrating cells is
replenished, increasing cellular mobility, which results in
the formation of metastatic colonies in remote locations
(Christofori and Bill, 2015). That is why the ability of tumor
cells to express markers characteristic of mesenchymal
and epithelial gene cells has been analyzed in this work.
It has been shown that IFNα-2b does not affect the
enhancement of the features that are characteristic of
cells of the mesenchymal phenotype, but it promotes
cell differentiation and expression of the markers of the
epithelial phenotype. Future work should concentrate
on exploring the possibility of combining IFNα-2b with
agents aimed at destroying or differentiating the cancer
stem cell population in targeted antitumor therapy.
Thus, we can conclude that IFNα-2b demonstrated
cytotoxic properties and capacity to reduce the intensity
of MCTS formation migration activity of breast cancer
cells. MCTSs are less sensitive to IFNα-2b due to
different cell populations in its composition. Changing
the growth of the tumor population causes changes in
the expression of epithelial and mesenchymal markers.
Thus, the percentage of epithelial markers in MCTSs
is less than in monolayer cells; however, spheroid cells
begin expressing a mesenchymal marker: vimentin. In
the 2D culture, tumor cell culture of IFNα-2b promoted
increased expression of CK and EpCAM by 50.5% and
47.8%, respectively, as compared to the control. In the 3D
cell culture, this increase was 33% and 34%, respectively,
compared to the control. In MCTSs only the outer cell
layers expressed these proteins, unlike adhesive cells, which
all showed equal expression. As there was an increase in
the expression of epithelial markers and the expression
of vimentin was not significantly different from that of
the control, it can be concluded that IFNα-2b positively
affects the acquisition of signs of differentiation, as well as
causing a decrease in the migration capacity of tumor cells
in the early stage of breast cancer development. Thereby,
MCTSs may be considered as a model for studying the
EMT process in vitro and as a test system with IFNα-2b
for immunomodulatory anticancer therapy.

References
Bekisz J, Baron S, Balinsky C, Morrow A, Zoon KC (2010).
Antiproliferative properties of type I and type II interferon.
Pharmaceuticals 3: 994-1015.
Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC (2004).
Human interferons alpha, beta and omega. Growth Factors 22:
243-251.
Bjerkvig R (1991). Spheroid Culture in Cancer Research. London,
UK: Taylor & Francis.

Chawla-Sarkar M, Leaman DW, Borden EC (2001). Preferential
induction of apoptosis by interferon (IFN)-β compared
with IFN-α2: correlation with TRAIL/Apo2L induction in
melanoma cell lines. Clin Cancer Res 7: 1821-1831.
Christofori G, Bill R (2015). The relevance of EMT in breast cancer
metastasis: correlation or causality. FEBS 589: 1577-1587.
Erenler AŞ, Geçkil H (2014). Triumph or tragedy: progress in cancer.
Turk J Biol 38: 701-707.

19

HERHELIUK et al. / Turk J Biol
Friedrich MJ (2007). Studying cancer in 3 dimensions. 3-D models
foster new insights into tumorigenesis. JAMA 18: 1977-1979.
Grana X, Reddy EP (1995). Cell cycle control in mammalian cells:
role of cyclins, cyclin dependent kinases (CDKs), growth
suppressor genes and cyclin-dependent kinase inhibitors
(CKIs). Oncogene 11: 211-219.
Gurski L, Petrelli N, Jia X, Farach-Carson M (2010). 3D matrices for
anti-cancer drug testing and development. Oncol Issues 25:
20-25.
Hanahan D, Coussens LM (2012). Accessories to the crime: functions
of cells recruited to the tumor microenvironment. Cancer Cell
21: 309-322.
Hsu YA, Huang CC, Kung YJ (2016). The antiproliferative effects
of type I IFN involve STAT6-mediated regulation of SP1 and
BCL6. Cancer Let 375: 303-312.
Kadegidze ZG, Slavina EG, Chertkova AI (2013). Interferon-gamma
in oncology. Pharmateka 17: 46-49 (in Russian).
Kim JB (2005). Three-dimensional tissue culture models in cancer
biology. Semin Cancer Biol 15: 365-377.
Kim YJ, Koo GB, Lee JY, Moon HS, Kim DG, Lee DG, Lee JY, Oh
JH, Park JM, Kim MS (2014). A microchip filter device
incorporating slit arrays and 3-D flow for detection of
circulating tumor cells using CAV1-EpCAM conjugated
microbeads. Biomaterials 35: 7501-7510.
Lamouillle S, Xu J, Derynck R (2014). Molecular mechanisms of
epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:
178-196.
Lisyany NI, Semenova VM, Lubich LD (2004). Achievements
and problems of interferon application in neurooncology.
Ukrainian Neurosurgical Journal 3: 29-36 (in Russian).
Ma H, Jin S, Yang W, Tian Z, Liu S, Wang Y, Zhou G, Zhao M,
Gvetadze S, Zhang Z
et al. (2017). Interferon-α promotes the expression of cancer stem
cell markers in oral squamous cell carcinoma. J Cancer 8: 23842393.
Marcucci F, Stassi G, DeMaria R (2016). Opinion: Epithelial–
mesenchymal transition: a new target in anticancer drug
discovery. Nature Reviews Drug Discovery 15: 311-325.

20

Morak MJ, van Koetsveld PM, Kanaar R, Hofland LJ, van Eijck CH
(2011). Type I interferons as radiosensitisers for pancreatic
cancer. Eur J Cancer 47: 1938-1945.
Mossman T (1983). Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assay.
Journal of Immunological Methods 65: 55-63.
Ningrum RA (2014). Interferon alpha2b: a therapeutic protein for
cancer treatment. Scientifica 2014: 1-8.
Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD,
Gilbert JR, Shekhtman EM, Tomei LD, Umansky SR, Kiefer
MC (1997). Interferon-gamma modulates a p53-independent
apoptotic pathway and apoptosis-related gene expression. J
Biol Chem 272: 16351-16357.
Semesiuk N, Lykhova O, Vorontsova AL, Bezdenezhnykh NO,
Kudryavets YuI (2011). The role of interferon as modifier of
epithelial-mesenchymal transition in tumor cells. Exp Onco
33: 178-181.
Suarez-Carmona M, Lesage J, Cataldo D, Gilles C (2017). EMT and
inflammation: inseparable actors of cancer progression. Mol
Oncol 11: 805-823.
Szeps M, Erickson S, Gruber A, Castro J, Einhorn S, Grandér D
(2003). Effects of interferon-alpha on cell cycle regulatory
proteins in leukemia cells. Leuk Lymphoma 44: 1019-1025.
Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt
O, Castro J, Einhorn S, Grandér D (2002). Mechanisms
of Interferon-alpha induced apoptosis in malignant cells.
Oncogene 21: 1251-1262.
Vidyasekar P, Shyamsunder P, Sahoo SK (2016). Scaffold-free and
scaffold-assisted 3D culture enhances differentiation of bone
marrow stromal cells. In Vitro Cell Dev Biol Anim 52: 204-217.
Vinci M, Box C, Zimmermann M (2013). Tumor spheroid-based
migration assays for evaluation of therapeutic agents. Methods
Mol Biol 986: 253-266.
Zarour HM (2016). Reversing T-cell dysfunction and exhaustion in
cancer. Clin Cancer Res 22: 1856-1864.
Zhao Z, Ma X, Sung D, Li M, Kosti A, Lin G, Chen Y, Pertsemlidis
A, Hsiao TH, Du L (2015). Microrna-449a functions as a
tumor suppressor in neuroblastoma through inducing cell
differentiation and cell cycle arrest. RNA Biol 12: 538-554.

